Eylea HD Interactions
No drug interactions were found for Eylea HD (aflibercept ophthalmic). However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Eylea HD (aflibercept ophthalmic) is in the drug class anti-angiogenic ophthalmic agents. Eylea HD (aflibercept ophthalmic) is used to treat the following conditions: Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Macular Edema, Macular Edema Following Retinal Vein Occlusion , Retinopathy of Prematurity.
Eylea HD disease interactions
There is 1 disease interaction with Eylea HD (aflibercept ophthalmic) which include:
More about Eylea HD (aflibercept ophthalmic)
- Eylea HD consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.